Children born to mothers who had COVID-19 during pregnancy may be more likely to develop obesity, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. More than 100 million COVID-19 cases have been reported in the United States since 2019, and there is limited information on the long-term health effects of the...
COVID-19 vaccination is safe, effective, and especially important in people with diabetes due to the risk of more severe outcomes. While a session at ENDO 2022 emphasized the vaccine’s safety in this population, more research is needed as to whether the virus is a causal factor to an increase in new-onset type 1 diabetes cases. ...
Language and cultural barriers are often a challenge when treating underserved Hispanic populations, which was only exacerbated by the COVID-19 pandemic. However, Ricardo Correa, MD, EdD, and Licy L. Yanes Cardozo, MD, tell Endocrine News how to improve care delivery to these patients, and how the solutions could be simpler than you think. Last month,...
ENDO 2022 was once again a hotbed of new research as people convened in person and online from around the world. Here, we look at two international researchers who shared their COVID-19 studies in poster presentations that looked at the pandemic’s impact on thyroid function, thyroid dysfunction, and the impact on women’s ovulatory cycles. ENDO...
Women’s reproductive health has been disrupted as a result of the psychological burden of the COVID-19 pandemic, and affected women need additional medical and psychological support, according to research presented at the Society for Endocrinology annual conference in Edinburgh last November. The findings indicate that stress and sleep disturbance related to the pandemic have had...
COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study in Cell Metabolism. Researchers led by James C. Lo, MD, PhD, an associate professor of medicine in the Weill Center for Metabolic Health and the Cardiovascular Research Institute at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, found that hyperglycemia is common in hospitalized COVID-19 patients and...
This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific...
Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes are at higher risk for COVID-19-related complications, especially if they are over the age of...
Language and cultural barriers are often a challenge when treating underserved Hispanic populations, which was only exacerbated by the COVID-19 pandemic. However, Ricardo Correa, MD, EdD, and Licy L. Yanes Cardozo, MD, tell Endocrine News how to improve care delivery to these patients, and how the solutions could be simpler than you think. Last month,...
